Impaired cerebral glucose metabolism is a pathologic feature of Alzheimer’s disease (AD), with recent proteomic studies highlighting disrupted glial metabolism in AD. We report that inhibition of indoleamine-2,3-dioxygenase 1 (IDO1), …
Category:
12345678..........................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....